60 years of Diabetes Care, Research, Education & Training in Diabetes
Shabana Tharkar, Vijay Viswanathan - Chennai Slim & Fit Programme (Awareness & Perceptions related to obesity among urban children & adolescents - TAPI Journal Vol 2, Issue 1, January, April, 2010.
Shabana Tharkar, Kumpatla Satyavani, P.Muthukumaran, Vijay Viswanathan - High Prevalence of Metabolic Syndrome and Cardiovascular Risk among police personnel compared to general population in India - JAPI - Vol - 56- November-2008.
Vijay Viswanathan, J. Janifer Jasmine, C. Snehalatha, A. Ramachandran. Prevalence of pathogens in diabetic foot infection in south Indian type 2 diabetic patients - JAPI, Vol. 50, Aug. 2002, 1013 - 1016.
Vijay Viswanathan, Uma Mahesh, M Jayaraman, K Shina, A Ramachandran. Beneficial role of granulocyte colony stimulating factor in foot infection in diabetic patients. JAPI, Vol. 51, January 2003.
Vijay Viswanathan, Sanjeev V, Kelkar DK, Seena R, Mamtha B Nair, A Ramachandran. Validation of indigenously made biothesiometer. The Asian Journal of Diabetology, 2003; 5(3): 13 - 14.
Vijay Viswanathan, HR Badrinath, C. Snehalatha, R.M. Bhoopathy , B. Mamta Nair, R Seena, M.P. Varadha Rani, A Ramachandran. Effect of treatment with the combination of Alpha - lipoic acid, chromium and inositol on diabetic peripheral neuropathy. The Asian Journal and Diabetology, September 2003, Vol. 5 (9); Pg. 9 - 15.
Vijay Viswanathan, Seena R, Mamtha B Nair, Snehalatha C, Bhoopathy RM, Ramachandran A. Nerve conduction abnormalities in different stages of glucose intolerance. Neurology India, 2004; 52 (4): 466 - 469.
Vijay Viswanathan, N. Thomas, N Tandon, A Asirvatham, Seena Rajasekar, A Ramachandran, K Senthilvasan, V.S. Murugan, Muthulakshmi. Profile of diabetic foot complications and its associated complications - A multicentric study from India. JAPI 2005; 53: 933 - 936.
Vijay Viswanathan. Diabetic nephropathy in type 2 diabetes: the Indian experience. JAPI vol. 49; December 2001, 1185 - 1187.
Vijay Viswanathan, B Mamtha Nair. Diabetic Nephropathy: The medical catastrophe in type 2 diabetes. Endocrine news letter, vol 11, No. 3, 2001.
Vijay Viswanathan, C Snehalatha, K Shina, A Ramachandran. Persistent microalbuminuria in type 1 diabetic subjects in south India. JAPI 2002; 50: 1259 - 1261.
Vijay Viswanathan, C Snehalatha, MP Varadharani, B Mamtha Nair, M Jayaraman, A Ramachandran. Prevalence of albuminuria among vegetarian and non-vegetarian south Indian diabetic patients. Indian J Nephrol 2002; 12: 73 - 76.
Vijay Viswanathan. Diabetes could cost you your kidneys, act now!. JAPI November 2003, vol. 51, 1043 - 1044.
Vijay Viswanathan, C Snehalatha, B Mamtha Nair, A Ramachandran. Validation of a method to determine albumin excretion rate in type 2 diabetes mellitus. The Indian Journal of Nephrology 13; 2003: 85 - 88.
Vijay Viswanathan, C Snehalatha, R Kumutha, B Mamtha Nair, A Ramachandran. Impact of joint national committee VII recommendations on diabetic microvascular complications. JAPI 2004; 52: 873 - 876.
Vijay Viswanathan, C Snehalatha, R Kumutha, Muthu Jayaraman, A Ramachandran. Serum albumin levels in different stages of type 2 diabetic nephropathy patients. Indian J Nephrol 2004; 14: 89 - 92.
Vijay Viswanathan. Prevention of diabetic nephropathy: A Diabetologist’s perspective. Indian J Nephrol 2004; 14: 157 - 162.
Vijay Viswanathan, C Snehalatha, Mamtha B Nair, A Ramachandran. Comparative assessment of cystatin C and creatinine for determining renal function. Indian J Nephrol 2005; 15: 91 - 94.
Vijay Viswanathan, Sheethal Suresh, Mamtha B Nair, Snehalatha C, Ramachandran A. Microalbuminruia: A Risk factor for abnormal pulse wave velocity. Indian J. Cardiol 2005; 8: 9 -12.
Vijay Viswanathan, Sivagami, Seena Rajasekar. Diabetic Foot: An Indian Scenario. The Asian Journal of Diabetology (special issue), Vol 7, No.3, Pg 9 - 11, 2005.
Vijay Viswanathan. Management of diabetes in chronic renal failure. Indian J Nephrol 2005; 15, Supplement1: S23 - S31.
Vijay Viswanathan, P.T. Chacko, M. Lavanya, Priyanka Tilak. A Proof of Concept, preliminary study to determine the effect of yogasnas in controlling type 2 diabetes mellitus in newly detected subjects (when compared to metformin monotherapy). JAPI 2006; 54: 965 - 966.
Vijay Viswanathan, M.Clementina, B.Mamtha Nair, K.Satyavani. Risk of future Diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance ? JAPI, Vol. 55, 833-837, December, 2007.
Risk of Diabetes in Subjects with Sedentary Profession and the Synergistic Effect of Positive Family History of Diabetes. Vigneswari A, Satyavani K, Manikandan R,Rajeswari Rajan, Vijay V. Diabetes Technology & Therapeutics. 2014. Vol 16(1): 26 – 32.PMID: 24116832
Effect of diabetes on treatment outcome of smear-positive pulmonary tuberculosis— A report from South India. Vijay V, Vigneswari A, Selvan K, Satyavani K,. Rajeswari R, Anil Kapur. Journal of Diabetes and Its Complications 28 (2014) 162–165. - PMID: 24461545
Incidence of cardiovascular diseases and associated risk factors among subjects with type 2 diabetes e An 11-year follow up study. Umamahesh K, Vigneswari A, Surya Thejaswi G, Satyavani K, Vijay V. Indian heart journal 2014; 66: e 5- 10 - PMID: 24035281
Direct cost associated with chronic kidney disease among type 2 diabetic patients in India. Satyavani K, Hemalatha K, Jayaraman M, Vijay V. Indian J Nephrology 2014; 24(3): 141 – 147.
Global guideline for type 2 diabetes. International Diabetes Federation Guideline Development Group. Diabetes Res Clin Pract. 2014 Apr;104(1):1-52. -PMID: 24508150
Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone. Pareek A, Chandurkar N, Thomas N, Vijay V, Deshpande A, Gupta OP, Shah A, Kakrani A, Bhandari S, Thulasidharan NK, Saboo B, Devaramani S, Vijaykumar NB, Sharma S, Agrawal N, Mahesh M, Kothari K. Curr Med Res Opin. 2014 Jul;30(7):1257-66 - PMID: 24669876
Comparison of plasma adiponectin & certain inflammatory markers in angiographically proven coronary artery disease patients with & without diabetes – A study from India. Satyavani K, Kirubakaran K, Sathyamurthy I, Parthiban M, Jayanthi K, Srinivasan KN, Vijay V. Ind J Medical Research 2014; 139: 841 – 850 - PMID: 25109718
Insulin Degludec – A novel ultra – long acting basal insulin analogue. Vijay V, TAPIJ 2014; 6(1): 6 – 10.
An aggressive and multi-pronged approach to prevent amputation in India. Vijay V. IJDDC 2014; 33(3): 123-124
An interesting case of hyponatremia. Jaiganesh M, TAPIJ 2014; 6(2): 22 – 24.
Rodiographic abnormalities in the feet of diabetic patients with neuropathy and foot ulceration. Vijay V, Satyavani K. Narayana Rao N. JAPI 2014; 62(11): 30-34 PMID: 26281477
Opportunistic screening of legal professional for diabesity and hypertension. Vijay V, Muruganathan A, Manikandan R, Vigneswari A, Satyavani K. TAPI J 2014; 6(3): 15 – 18.
A Simple and Specific Method for Estimation of Lipoic Acid in human Plasma by High Performance Liquid Chromatography. Ezhilarasi K, Sudha V, Geetha Ramachandran, Dhamodharan U, Rama Rajaram, Indira Padmalayam, Vijay V and Hemanth Kumar AK. J Chromat Separation Techniq 2014; 5( 6): 1000245 (Open Access journal)
Effect of a comprehensive training programme for tuberculosis health care providers and tuberculosis patients on diabetes – a report from south India. Vijay V, Vigneswari A, satyavani K, selvan K, Rajeswari R, Kapur A. Int J of Tropical Dis 2015; 5(1): 91-100
Double burden of diabetes and TB – Experience in India. Vijay V, Satyavani S, Anitha R. Diabetes Voice 2015; 60(1): 22 – 24.
Preventing microvascular complications in type1diabetes mellitus. Vijay V. Ind J Endo and metabolism 2015, vol 19(suppli1): S36 – 38. PMID: 25941647
Type 1 diabetes: Awareness, management and challenges: Current scenario in India. K.M. Prasanna Kumar, Banshi Saboo, P.V. Rao, Archana Sarda, Vijay V, Sanjay K, Bipin Sethi, Nalini Shah, S.S. Srikanta, Sunil M Jain, P. Raghupathy, Rishi Shukla, Ashok Jhingan, Subhankar Chowdhury, P.K. Jabbar, Alok Kanungo, Rajesh Joshi, Surendra Kumar, Nikhil Tandon, Vaman Khadilkar, Manoj Chadha. Ind J Endo & Metabolism, 2015;19(supli1):S6 – 8. PMID 25941655
Topical administration of a connexin43-based peptide augments healing of chronic neuropathic diabetic foot ulcers: A multicenter, randomized trial.Grek CL, Prasad GM, Vijay V, Armstrong DG, Gourdie RG, Ghatnekar GS.Wound Repair Regen. 2015 Mar;23(2):203-12. PMID: 25703647
Genetic association of IL-6, TNF-α and SDF-1 polymorphisms with serum cytokine levels in diabetic foot ulcer. Umapathy Dhamodharan, Vijay Viswanathan, Ezhilarasi Krishnamoorthy, Rama Rajaram, Vivekanandhan Aravindhan. Gene, 2015 Jul 1;565(1):62-7. PMID: 25839939
An assessment of fear of self injecting and self testing in insulin treated diabetic patients and its impact on HbA1c. Sripriya S, Anu Jij, Satyavani K, Vijay V. TapiJ 2015; 7(1): 1 – 4.
Clinical significance of urinary liver‑type fatty acid binding protein at various stages of nephropathy Vijay V, S Sivakumar, V Sekar, D Umapathy1, S Kumpatla Ind J Nephrology 2015; 25(5): 269-273.
Novel insulin co-formulation of insulin degludec and insulin aspart (IDegAsp): advancement in diabetes management. Vijay V. TapiJ 2015; 7(2): 1-9.
Impact of the hypoxia inducible factor-1α (HIF-1α) pro582ser polymorphism and its gene expression on diabetic foot ulcers. Pichu S, Jayalalitha S, Ezhil K, Dhamodharan U, Vijay V. Diabetes Res Clin Pract. 2015 Sep;109(3):533-40
Prevalence of risk factors of diabetes among urban Poor South Indian population A Vigneswari, R Manikandan, K Satyavani, S Archana, R Rajeswari, Vijay V. Japi 2015; 63(10): 32-34.
Global Increase in the Prevalence of Diabetes with Special Reference to the Middle East and Asia. Vijay V, Saigopal S. Diabetes Technol Ther. 2015 Oct;17(10):676-8.
Effect of yogasanas on glycaemic, haemodynamic and lipid profile in newly diagnosed subjects with type 2 diabetes. Satyavani K, Clementina M, Vijay V. IJDDC, 2015; 35( Suppl 2), pp 181-188
Assessment of depression among type 2 diabetic patients with complications and without complications. Sripriya S, Elayaraja B, Satyavani K, Vijay V. IJDDC 2015, Volume 35, Issue 3, pp 310-313
15. Sex differences in cardiovascular risk factors among people with diabetes in South India. Satyavani K, Archana S, Ajay MV Kumar, Shanta A, Vijay V. Japi 2015; 63(12): 20 – 24.
Effect of structured behaviour intervention program on Childhood Obesity. Vijay V, Khan BKS, Vigneswari A, Selvan K, Rajeswari R. Saigopal S. Int J of TRO DIS & Health 2016; 11(4): 1-8.
Socio-Economic Factors Relating to Diabetes and its Management in India. Shrivastava U, Misra A, Gupta R, Vijay V. J Diabetes. 2016; Vol: 8(1): 12-23 PMID: 26019052
High Prevalence and Heterogeneity of Diabetes in TB Patients from South India: A Report from the Effects of Diabetes on Tuberculosis Severity (EDOTS) Study. Kornfeld H, West K, Kane K, Kumpatla S, Zacharias RR, Martinez-Balzano C, Li W, Viswanathan V. Chest. 2016; 149(6): 1501-8. PMID: 26973015
“Living with type 1 diabetes: Life story of Pallavi” Journal of Social Health and Diabetes / Vol 4 / Issue 1 / Jan-Jun 2016
Use of Retrospective Continuous Glucose Monitoring for Optimizing Management of Type 2 Diabetes in India. Mohan V, Sunil Jain, Jothydev K, Manoj C, Abhay M, Vijay V, Banshi S, Rajiv K, Ambrish M, Dharmen P, John S. JAPI 2016: 64(4): 16 – 21. PMID: 27734636
Double burden of diabetes and tuberculosis. Vijay V, Saigopal S, Satyavani K. World Clinics Diabetology 2016; 2(1): 23-29. ISBN : 9789352501649
Diabetes – an ancient disease, epicdemic & an economic burden for the present era. Vijay V and Smriddhi Ranjan. Ind J Med Res, 2016; 143(4): 11-13. PMID: 27377490
Presence of elevated non-HDL among patients with T2DM with CV events despite of optimal LDL-C – A report from South India. Satyavani K, Anju Soni, S.N. Narasingan, Vijay V. Indian Heart J. 2016 May-Jun; 68(3): 378–379. PMID: 27316499
Optimizing Technology Use for Chronic Lower-Extremity Wound Healing: A Consensus Document. Mani R, Margolis DJ, Shukla V, Akita S, Lazarides M, Piaggesi A, Falanga V, Teot L, Xie T, Bing FX, Romanelli M, Attinger C, Han CM, Lu S, Meaume S, Xu Z,Vijay V. Int J Low Extrem Wounds. 2016 Jun;15(2):102-19. Review. PMID: 27207900
Dual role of transforming growth factor (TGFβ) in diabetic nephropathy – A Review. Anitha rani A and Vijay V. TAPIJ 2016; 8 (1) Jan – Apirl: 5 – 10.
Best practices from Changing Diabetes® in Children India K. M. Prasanna Kumar, Nalini Shah, Vijay V, Archana Sarda, Shuchy Chugh, Dinakaran P. J Social Health and Diab 2016, 4 (2): 137-140
Effect of standard tuberculosis treatment on naive, memory and regulatory T cell homeostasis in tuberculosis-diabetes co-morbidity. Kumar NP, Moideen K Vijay V, Kornfeld H, Babu S. Immunology. 2016 Sep;149(1): 87-97. PMID: 27289086
Impact of the Gather mHealth System on A1C: Primary Results of a Multisite Randomized Clinical Trial Among People With Type 2 Diabetes in India. Kleinman NJ, Shah A, Shah S, Phatak S, Vijay V. Diabetes Care. 2016 Oct;39(10): e169-70. PMID: 27493133
Effectiveness of a Multicomponent Quality Improvement Strategy to Improve Achievement of Diabetes Care Goals: A Randomized, Controlled Trial. Ali MK, Singh K, Kondal D, Devarajan R, Patel SA, Shivashankar R, Ajay VS, Unnikrishnan AG, Menon VU, Varthakavi PK, Viswanathan V, Dharmalingam M, Bantwal G, Sahay RK, Masood MQ, Khadgawat R, Desai A, Sethi B, Prabhakaran D, Narayan KM, Tandon N; CARRS Trial Group. Ann Intern Med. 2016 Sep 20; 165 (6):399-408. PMID: 27398874.
Replication of genome-wide association signals in Asian Indians with early-onset type 2 diabetes. Chidambaram M, Samuel Liju, Banshi Saboo, Satyavani K, Vijay V, Pankratz N, Myron Gross, Mohan V. Acta Diabetol 2016; Dec 53(6): 915 - 923. PMID:27488727
Effect of a polyherbal formulation cream on diabetic neuropathic pain among patients with type 2 diabetes - A pilot study. Vijay V, Seena R, Bamila S, Satyavani K. IJMR 2016; 144(2): 215 – 219.
Modulation of dendritic cell and monocyte subsets in tuberculosis-diabetes co-morbidity upon standard tuberculosis treatment. Kumar NP, Moideen K, Sivakumar S, Menon PA, Vijay V, Kornfeld H, Babu S. Tuberculosis (Edinb). 2016; Dec 101: 191-200. PMID: 27865391